Piotech Surpassed 3800 Reaction Chambers, but Its 13-Fold Profit Jump Needs Context

Piotech surpassed 3800 cumulative reaction-chamber shipments as its first-half net profit increased more than thirteenfold. Yet equipment sales alone did not produce that profit surge.

The Chinese semiconductor-equipment manufacturer reported first-half revenue of 2.913 billion yuan, up 49.06 percent year over year. Net profit attributable to shareholders reached 1.343 billion yuan, an increase of 1,324.1 percent.

Those figures arrived with an important accounting qualification. The increase in fair-value gains from financial assets was approximately 960 million yuan, according to the company’s results summarized in an August 20 report.

That gain represented most of the year-over-year increase in reported net profit, although the two amounts are not directly comparable before tax. Piotech’s manufacturing business still expanded quickly, but headline earnings overstate the underlying operational acceleration.

The more consequential development sits inside the shipment data. Piotech says its equipment has entered about 100 production lines, compared with more than 70 lines reported one year earlier.

That expanding installed base puts pressure on Applied Materials, Lam Research, and other international vendors serving Chinese logic and memory manufacturers. It also raises the standard Piotech must meet on reliability, service, and repeat orders.

The 3800 Figure Measures an Installed Base, Not Six Months of Sales

Piotech’s milestone reflects cumulative deployment across customer factories, not 3800 chambers shipped during the first half.

A reaction chamber is the controlled module where gases and plasma create thin films on a semiconductor wafer. A single production tool can contain multiple chambers, so chamber counts do not equal machine counts.

Piotech reported more than 3800 cumulative reaction chambers shipped by the end of June 2026. That total included over 480 newer pX and Supra-D chambers.

The equipment had entered approximately 100 production lines. Piotech also said its thin-film systems had processed about 600 million wafers across customer facilities.

These figures provide several distinct adoption signals. Chamber shipments show the scale of installed process capacity. Production-line coverage indicates customer deployment breadth, while processed wafers suggest that systems are operating beyond initial evaluation.

The milestone continues a visible expansion from the previous year. In August 2025, Piotech reported more than 3,000 cumulative chambers, including over 340 pX and Supra-D chambers.

Its equipment had then entered more than 70 production lines. Moving from those levels to the latest totals indicates at least 800 additional chambers and roughly 30 more production lines.

However, the exact number shipped during the six-month reporting period remains unclear. “More than” figures also prevent precise calculations of installation growth or market share.

Piotech reported average uptime above 90 percent for thin-film deposition systems at customer sites. Uptime is the share of scheduled production time during which equipment remains available for manufacturing.

The company says that performance is comparable with international equipment. The claim matters because semiconductor manufacturers judge tools through repeatable yield, availability, maintenance demands, and total production cost.

A chamber entering a factory does not automatically prove sustained high-volume performance. Acceptance testing, repeat purchases, and years of stable operation provide stronger evidence than a cumulative shipment total alone.

Still, deployment across about 100 lines changes Piotech’s position. It gives the company more operating data, service experience, and opportunities to qualify additional processes with existing customers.

Each installed chamber also creates future maintenance and upgrade requirements. That relationship can make an established supplier harder to replace once its equipment becomes integrated into production recipes.

Piotech’s milestone therefore signals more than shipment volume. It shows that a domestic Chinese supplier has accumulated a meaningful field population in one of chipmaking’s most process-sensitive equipment categories.

Revenue Growth Shows the Manufacturing Business Is Scaling

The operating business expanded substantially even after separating it from the financial gain that inflated reported earnings.

First-half revenue reached 2.913 billion yuan, compared with approximately 1.954 billion yuan one year earlier. That 49.06 percent increase extended the growth recorded in Piotech’s 2025 annual filing.

Revenue for all of 2025 was 6.519 billion yuan, up 58.87 percent. Plasma-enhanced chemical vapor deposition, or PECVD, supplied most of that annual revenue.

PECVD uses plasma to deposit thin films at lower temperatures than many conventional thermal processes. It is central to insulating layers, protective films, and complex structures in logic and memory chips.

Piotech said several PECVD products continued moving into volume production during the first half. These included Stack applications for oxide-nitride-oxide layers and its ACHM process equipment.

The company also cited OPN, SiB, and Bianca products as expanding their production scale and generating revenue. Customers reportedly completed batch validation for several advanced products.

Piotech’s atomic layer deposition business also grew. ALD builds extremely thin films through sequential surface reactions, giving manufacturers precise thickness control on three-dimensional structures.

Multiple PE-ALD systems for silicon dioxide and silicon carbon oxide reportedly received repeat-order validation. The company said those deployments began contributing revenue during the period.

Repeat orders matter more than an initial evaluation unit. They indicate that a customer has gathered enough performance evidence to purchase additional capacity for the same process.

Manufacturing economics improved alongside revenue. Piotech reported a 41 percent gross margin, approximately nine percentage points higher than one year earlier.

Cost of revenue increased 29.24 percent, or about 389 million yuan. That was well below the 49.06 percent growth in sales.

Piotech attributed the difference to production scale and the volume adoption of newer products and processes. Greater production volume can spread engineering, procurement, and facility costs across more delivered systems.

The second quarter also remained stronger than the first on reported earnings. Net profit reached 772 million yuan, versus 571 million yuan during the first quarter.

That represents a sequential increase of about 35 percent. It does not, however, isolate recurring equipment profitability from investment-related changes inside either quarter.

Piotech’s growth arrives during an unusually favorable spending cycle. A July equipment forecast projected global semiconductor-manufacturing equipment sales of $165.9 billion in 2026.

The forecast represents 23.2 percent annual growth. It also projects wafer-fabrication equipment sales of $143.9 billion, up 23.1 percent.

AI infrastructure is driving investment in advanced logic, high-bandwidth memory, and denser three-dimensional device architectures. Each trend increases demand for deposition, etch, inspection, bonding, and packaging equipment.

China, Taiwan, and Korea are expected to remain the three largest equipment-spending destinations through 2028. Piotech therefore operates where both market expansion and localization demand are unusually concentrated.

The 13-Fold Profit Increase Is Not the Same as Operating Growth

Piotech’s earnings headline combines a stronger equipment business with a financial gain that investors should analyze separately.

Net profit attributable to shareholders rose from about 94.3 million yuan in the first half of 2025 to 1.343 billion yuan. That produced the reported 1,324.1 percent increase.

The absolute year-over-year improvement was approximately 1.249 billion yuan. Meanwhile, the increase in fair-value gains from trading financial assets was about 960 million yuan.

Those figures use different accounting and tax bases, so they should not be subtracted mechanically. Still, their relative size makes the source of the headline increase impossible to ignore.

The investment-related change equaled roughly three quarters of the absolute increase in attributable net profit. That does not mean three quarters of profit came directly from one asset movement.

It does mean readers cannot treat the thirteenfold increase as a clean measure of equipment sales, manufacturing efficiency, or customer adoption. The gain can also reverse if asset values move against the company.

Gross margin offers a better window into operational progress. A nine-point increase suggests that product mix, production scale, or manufacturing costs improved materially.

Revenue growth provides another recurring indicator. A 49.06 percent increase is substantial even without the financial gain, especially following rapid expansion during 2025.

The number of production lines and repeat-order validations adds further operational evidence. These indicators connect reported sales with installations and customer use.

However, Piotech did not identify its customers in the half-year announcement. Semiconductor-equipment contracts often remain confidential because process configurations reveal manufacturing strategies.

That confidentiality limits outside verification. Readers cannot independently determine how many lines represent sustained high-volume production, pilot capacity, or equipment still progressing through qualification.

The cumulative chamber figure has another limitation. It does not disclose revenue per chamber, chamber utilization, customer concentration, or the service burden created by the installed base.

Newer pX and Supra-D chambers accounted for more than 480 cumulative shipments. That is meaningful, but it represents only part of the total population.

Older platforms can support revenue while also requiring more maintenance. Newer platforms can improve performance but carry qualification costs and early reliability risks.

A higher gross margin during one reporting period does not settle those questions. Future filings must show whether the improvement survives a changing product mix and stronger domestic competition.

The planned interim dividend also draws attention to earnings quality. Piotech proposed distributing 3.5 yuan for every ten shares, subject to the required corporate process.

A dividend can return cash to shareholders, but it does not convert fair-value gains into recurring operating income. Cash flow and balance-sheet disclosures remain necessary for that assessment.

The appropriate conclusion is narrower than the headline. Piotech’s operations strengthened, and reported profit rose dramatically, but the two developments did not occur at the same rate.

Piotech Is Challenging Imported Tools Through Factory Qualification

The central competition is not domestic equipment versus foreign equipment on specifications, but qualified production capacity versus established factory relationships.

Applied Materials and Lam Research have spent decades building process expertise, field-service networks, and customer trust. Their tools support critical deposition steps across logic, memory, and advanced packaging.

Piotech does not need to replace every foreign system to gain share. It needs to qualify more processes, secure repeat orders, and expand within production lines where it already operates.

This makes the increase from more than 70 lines to about 100 lines strategically important. A new line can expose Piotech’s equipment to additional manufacturing teams and process requirements.

Chinese chipmakers have strong reasons to evaluate domestic alternatives. Export controls, supply-chain uncertainty, and national industrial policy have increased the value of locally available equipment and support.

Yet localization does not eliminate performance requirements. A deposition error can affect film thickness, electrical properties, wafer yield, and the reliability of every later manufacturing step.

Factories therefore qualify equipment process by process. A supplier that succeeds in one deposition application does not automatically receive approval for another film, device layer, or production node.

Piotech’s expanding portfolio addresses that constraint. Its PECVD, ALD, SACVD, HDPCVD, and Flowable CVD systems cover different pressure ranges, film properties, and gap-filling requirements.

That breadth lets Piotech pursue more spending inside the same factory. It also increases development costs because every process needs recipes, hardware tuning, and customer validation.

Domestic competition is growing at the same time. Naura sells a broad collection of Chinese semiconductor-production equipment, including deposition platforms.

Advanced Micro-Fabrication Equipment has also entered more deposition segments. These companies can compete for the same localization budgets while offering complementary tools elsewhere in a factory.

That competitive pressure creates a second test for Piotech. It must narrow performance gaps with international suppliers without surrendering margins to domestic price competition.

Foreign vendors are also broadening their advanced-manufacturing portfolios. Applied Materials introduced new systems for DRAM and three-dimensional AI chips in June 2026.

Its new manufacturing systems target materials engineering challenges across memory and advanced packaging. That portfolio connects deposition with surface preparation, planarization, and bonding.

Lam Research combines deposition, etch, and packaging equipment. Its packaging portfolio includes processes for high-yield die-to-wafer assembly.

These competitors sell more than individual machines. They offer process knowledge that spans several manufacturing steps and can reduce integration risk for large customers.

Piotech’s installed base gives it a route toward similar relationships inside China. Its challenge is proving that local availability comes with comparable yield, reliability, and process support.

The company’s reported uptime above 90 percent is relevant here. However, a company-reported average cannot reveal the distribution across individual products, customers, or process conditions.

International comparison also requires identical measurement methods. Scheduled downtime, maintenance windows, and customer operating practices can change the resulting percentage.

The competitive signal will therefore come from repeated customer behavior. Additional orders for the same chambers would support Piotech’s reliability claims more strongly than a single aggregate uptime figure.

Three-Dimensional Integration Expands the Opportunity and the Risk

Piotech is moving beyond front-end film deposition into bonding, where process integration matters as much as individual tool performance.

Three-dimensional integration connects dies or wafers vertically to shorten electrical paths and increase functional density. It supports advanced memory, image sensors, and high-performance computing.

Piotech has developed hybrid-bonding and fusion-bonding equipment, along with related measurement and inspection systems. It says those products now address advanced memory, advanced logic, and image-sensor applications.

Hybrid bonding joins copper interconnects and surrounding dielectric materials without relying on traditional solder bumps. The process demands exceptionally clean, flat, and accurately aligned surfaces.

Fusion bonding joins prepared surfaces through molecular attraction followed by thermal processing. Defects or trapped particles can create voids that reduce yield.

During the first half, Piotech expanded development around chip-to-wafer fusion bonding and bonding-interface void repair. It also reported adding several customers for its integration equipment.

These products give Piotech access to a different stage of semiconductor manufacturing. Deposition tools build films on wafers, while bonding equipment assembles separately manufactured layers into a larger structure.

The connection is technically useful. Thin-film deposition influences the surfaces and dielectric layers later used in bonding, so knowledge from one category can inform the other.

The commercial relationship is less automatic. Customers may buy deposition systems from one vendor and bonding, cleaning, metrology, or alignment equipment from several others.

Piotech must therefore prove that its bonding systems deliver competitive yield across an integrated process. Successful placement at one customer does not establish broad production readiness.

International suppliers already approach advanced packaging as a connected workflow. Applied Materials describes hybrid bonding as a process requiring near-perfect surface planarity for high-yield production.

Lam Research has explained how PECVD supports bonding by controlling films and wafer stress. Its work illustrates why deposition expertise can extend into packaging.

Piotech’s expansion follows the same industry logic. More AI accelerators and high-bandwidth memory require dense connections between compute, memory, and supporting dies.

This opportunity also raises development risk. Advanced packaging changes quickly, and customers can select different combinations of wafer-to-wafer, chip-to-wafer, or die-to-wafer bonding.

A tool designed for one flow may require significant changes for another. Inspection requirements also become stricter as bond pitches shrink and hidden interfaces become harder to evaluate.

Piotech has not disclosed detailed revenue for the new three-dimensional integration products in its first-half announcement. It also has not provided customer-level yields or installation numbers by bonding category.

That leaves a gap between portfolio expansion and commercial scale. The products may become a meaningful second growth engine, but current evidence does not establish that outcome.

The company’s Shenyang expansion adds another layer of execution risk. Its second manufacturing base has completed structural topping out and is expected to enter service in 2028.

The project covers more than 150,000 square meters and includes clean production areas, automated warehousing, and testing laboratories. It is intended to increase capacity for multiple deposition platforms.

Additional capacity can support more orders, but it also raises fixed costs. Piotech must fill the facility without sacrificing quality or allowing delivery growth to outpace field service.

Its existing installed base gives management a clearer demand signal than an early-stage supplier would possess. However, a factory scheduled for 2028 depends on conditions beyond the current spending cycle.

What Investors and Chipmakers Should Watch Next

Three signals will determine whether Piotech’s current momentum represents durable process adoption or a favorable reporting period.

The first signal is repeat-order growth for pX, Supra-D, and newer ALD chambers. Repeat purchases would show that customers are expanding capacity after operating the equipment.

The next filing should separate current-period shipments from the cumulative total. It should also clarify how many new production lines entered high-volume manufacturing.

A rising chamber count without similar growth in repeat orders would weaken the adoption case. Growth across both measures would strengthen it.

The second signal is recurring profitability after removing investment-related movements. Revenue growth, gross margin, operating cash flow, and adjusted earnings deserve more attention than headline net profit.

Piotech does not need another thirteenfold increase to validate its business. It needs margins that remain stable while newer products scale and domestic competition intensifies.

If gross margin stays near the first-half level while financial gains normalize, the operating improvement will look more durable. A sharp reversal would suggest that product mix or temporary factors played a larger role.

The third signal is measurable commercial progress in three-dimensional integration. Investors should look for repeat bonding-system orders, disclosed revenue growth, and wider customer qualification.

A named production application would be especially informative, although customer confidentiality may prevent disclosure. Shipment counts by equipment category would still improve visibility.

Success in bonding would expand Piotech beyond its established deposition base. Slow qualification would keep the business more dependent on conventional wafer-fabrication spending.

The global market provides a supportive background, not a guaranteed outcome. Current forecasts point toward continued growth in advanced memory, logic, packaging, and testing investment through 2028.

Piotech must convert that spending into qualified processes while managing stronger Chinese and international competition. It must also support every additional chamber already operating in customer factories.

The 3800 milestone is credible evidence of scale, but it is not a complete scorecard. The sharper question concerns what those chambers produce after installation.

Do customers place repeat orders, maintain high utilization, and approve Piotech for more demanding layers? Do bonding products advance from evaluation into volume manufacturing?

Readers should track those operational answers before treating the reported profit increase as a new baseline. Piotech’s equipment footprint is expanding quickly, while the quality of that expansion remains the decisive measure.